Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 93

1.

Distinct cellular interactions of secreted and transmembrane Ebola virus glycoproteins.

Yang Z, Delgado R, Xu L, Todd RF, Nabel EG, Sanchez A, Nabel GJ.

Science. 1998 Feb 13;279(5353):1034-7.

2.

Two strings to the bow of Ebola virus.

Klenk HD, Volchkov VE, Feldmann H.

Nat Med. 1998 Apr;4(4):388-9. No abstract available.

PMID:
9546777
3.

A method in Ebola's madness.

Wickelgren I.

Science. 1998 Feb 13;279(5353):983-4. No abstract available.

PMID:
9490485
4.

The glycoproteins of Marburg and Ebola virus and their potential roles in pathogenesis.

Feldmann H, Volchkov VE, Volchkova VA, Klenk HD.

Arch Virol Suppl. 1999;15:159-69. Review.

PMID:
10470276
5.

Identification of the Ebola virus glycoprotein as the main viral determinant of vascular cell cytotoxicity and injury.

Yang ZY, Duckers HJ, Sullivan NJ, Sanchez A, Nabel EG, Nabel GJ.

Nat Med. 2000 Aug;6(8):886-9.

PMID:
10932225
6.
7.

Release of viral glycoproteins during Ebola virus infection.

Volchkov VE, Volchkova VA, Slenczka W, Klenk HD, Feldmann H.

Virology. 1998 May 25;245(1):110-9.

8.

Cathepsins B and L activate Ebola but not Marburg virus glycoproteins for efficient entry into cell lines and macrophages independent of TMPRSS2 expression.

Gnirss K, Kühl A, Karsten C, Glowacka I, Bertram S, Kaup F, Hofmann H, Pöhlmann S.

Virology. 2012 Mar 1;424(1):3-10. doi: 10.1016/j.virol.2011.11.031. Epub 2012 Jan 4.

9.

Ebola virus secretory glycoprotein (sGP) diminishes Fc gamma RIIIB-to-CR3 proximity on neutrophils.

Kindzelskii AL, Yang Z, Nabel GJ, Todd RF 3rd, Petty HR.

J Immunol. 2000 Jan 15;164(2):953-8.

10.

The nonstructural small glycoprotein sGP of Ebola virus is secreted as an antiparallel-orientated homodimer.

Volchkova VA, Feldmann H, Klenk HD, Volchkov VE.

Virology. 1998 Oct 25;250(2):408-14.

11.

Cyanovirin-N binds to the viral surface glycoprotein, GP1,2 and inhibits infectivity of Ebola virus.

Barrientos LG, O'Keefe BR, Bray M, Sanchez A, Gronenborn AM, Boyd MR.

Antiviral Res. 2003 Mar;58(1):47-56.

PMID:
12719006
12.

Pre-transmembrane sequence of Ebola glycoprotein. Interfacial hydrophobicity distribution and interaction with membranes.

Sáez-Cirión A, Gómara MJ, Agirre A, Nieva JL.

FEBS Lett. 2003 Jan 2;533(1-3):47-53.

13.

Ebola virus glycoprotein-mediated anoikis of primary human cardiac microvascular endothelial cells.

Ray RB, Basu A, Steele R, Beyene A, McHowat J, Meyer K, Ghosh AK, Ray R.

Virology. 2004 Apr 10;321(2):181-8.

14.
15.

Shedding of Ebola Virus Surface Glycoprotein Is a Mechanism of Self-regulation of Cellular Cytotoxicity and Has a Direct Effect on Virus Infectivity.

Dolnik O, Volchkova VA, Escudero-Perez B, Lawrence P, Klenk HD, Volchkov VE.

J Infect Dis. 2015 Oct 1;212 Suppl 2:S322-8. doi: 10.1093/infdis/jiv268. Epub 2015 Jun 19.

PMID:
26092855
16.

Downregulation of beta1 integrins by Ebola virus glycoprotein: implication for virus entry.

Takada A, Watanabe S, Ito H, Okazaki K, Kida H, Kawaoka Y.

Virology. 2000 Dec 5;278(1):20-6.

17.

Isolation and phylogenetic characterization of Ebola viruses causing different outbreaks in Gabon.

Georges-Courbot MC, Sanchez A, Lu CY, Baize S, Leroy E, Lansout-Soukate J, Tévi-Bénissan C, Georges AJ, Trappier SG, Zaki SR, Swanepoel R, Leman PA, Rollin PE, Peters CJ, Nichol ST, Ksiazek TG.

Emerg Infect Dis. 1997 Jan-Mar;3(1):59-62.

18.

In vitro evaluation of cyanovirin-N antiviral activity, by use of lentiviral vectors pseudotyped with filovirus envelope glycoproteins.

Barrientos LG, Lasala F, Otero JR, Sanchez A, Delgado R.

J Infect Dis. 2004 Apr 15;189(8):1440-3. Epub 2004 Apr 1.

PMID:
15073681
20.

Supplemental Content

Support Center